Breakthrough innovation

突破性创新
  • 文章类型: Journal Article
    与增量创新相比,突破性创新对于保持竞争优势至关重要,但突破性创新具有高标准、严要求的特点。作为企业的主体和基础,员工的态度和行为对企业创新起着至关重要的作用。基于积极的组织行为理论和知识管理理论,本文的目的是研究心理资本与突破性创新之间的关系,我们还将隐性知识共享和任务相互依存纳入研究框架,从而进一步探索员工心理资本对突破性创新的影响机制。利用定量方法,本研究以云南咖啡企业员工为调查对象,通过SPSS24.0对数据进行回归分析,并通过Bootstrap检验进一步验证中介的存在.研究结果表明:员工心理资本对突破性创新有正向影响;隐性知识共享部分中介心理资本与突破性创新的关系;任务相互依赖起调节作用。也就是说,任务的相互依存性越强,员工心理资本对突破性创新的影响越强。本研究丰富了云南咖啡产业突破性创新影响因素的研究,拓展了相关理论的应用场景,强调心理资本的重要性和突破性创新是各种内外部资源相互作用和增值联动的结果。
    Compared with incremental innovation, breakthrough innovation is essential to sustaining competitive advantage, but breakthrough innovation has the characteristics of high standards and strict requirements. As the main body and foundation of enterprises, the attitude and behavior of employees play a vital role in enterprise innovation. Based on the positive organizational behavior theory and knowledge management theory, the purpose of this paper is to investigate the relationship between psychological capital and breakthrough innovation, and we also integrate tacit knowledge sharing and task interdependence into the research framework, so as to further explore the influence mechanism of employees\' psychological capital on breakthrough innovation. Utilizing a quantitative method, this study takes employees of Yunnan coffee enterprises as investigation objects, the data was analyzed using regression analysis through SPSS 24.0, and the existence of mediation was further verified by Bootstrap test. The results showed that the psychological capital of employees have a positive impact on breakthrough innovation; tacit knowledge sharing partially mediates the relationship between psychological capital and breakthrough innovation; and task interdependence plays a moderating role, that is, the stronger the task interdependence, the stronger the influence of employee psychological capital on breakthrough innovation. This study enriches the research on the influencing factors of breakthrough innovation of Yunnan coffee industry, expands the application scenarios of the related theory, emphasizes that the importance of psychological capital and the breakthrough innovation is the result of the interaction and value-added linkage of various internal and external resources.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    本文的目的是通过利益相关者模型的视角来研究生物制药创新生态系统(IE)。在这样做的时候,这项工作旨在回答以下研究问题:生物制药行业的IE需要哪些利益相关者,以及他们在IE价值创造中的主要作用是什么。研究策略是根据扎根理论方法设计的。通过应用这种方法,数据是通过与几个利益相关者的逐字访谈收集的。数据收集和数据分析阶段都同时进行,直到确定所有数据并达到多种形式的一致性为止。本文的论文旨在证明生物制药IE由多层次和纵向的关键利益相关者组成。此外,通过调查伦巴第的案例研究,它解释了每个利益相关者在参与IE所需的比较优势方面的作用。此外,从生物制药IE的整体观点出发,本研究通过分析IE的驱动力来追溯生物制药IE的动力学。本文代表了从整体角度分析深入生物制药IE的首批启发式尝试之一。论文的发现可以被认为是对全球生物制药IE的有效扩展。作为方法论的核心部分的专家访谈以及所调查的科学文献都很好地支持了这一更广泛的范围。
    The purpose of this paper is to examine biopharma innovation ecosystems (IEs) through the lenses of a stakeholder model. In doing so, this work aims to answer the following research question: which stakeholders are required in an IE within biopharma industry and what are their main roles in the IE value creation. The research strategy was designed according to the grounded theory methodology. By applying this methodology, data were collected through verbatim interviews with several stakeholders. Both data collection and data analysis phases were carried out concurrently up to saturation where all data were identified and their consistency across the many forms was reached. The thesis of the paper intends to prove that biopharma IEs consist of a multilevel and longitudinal set of key stakeholders. Furthermore, by investigating the Lombardy case study, it explains the role of each stakeholder with regards to the comparative advantages required in the engagement with the IE. In addition, arising from a holistic view of the biopharma IEs, this research traces the biopharma IE dynamics through the analysis of the IE\'s driving forces. This paper represents one of the first heuristic attempts to analyze in-depth biopharma IE from a holistic perspective. The paper findings can be considered to be an impactful extension to biopharma IEs world-wide. This broader scope is well supported by expert interviews as a central part of the methodology and by the investigated scientific literature.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号